LONP2

LONP2 is the peroxisomal isoform of the ATP-dependent Lon protease, functioning in peroxisomal protein quality control by selectively degrading oxidatively damaged proteins within the organelle and thereby maintaining peroxisomal protein homeostasis and prolonging organelle functional lifespan (PMID:29167332, PMID:26852705). A direct cellular substrate is the peroxisomal protease TYSND1, which accumulates upon LONP2 depletion; loss of LONP2 also alters peroxisome size and number and impairs luminal protein import, and disrupts cholesterol flux out of late endosomes (PMID:37736739). LONP2 is transcriptionally controlled by a peroxisomal retrograde signaling pathway: peroxisomal import stress induces NHR-49/PPARα- and MDT-15/MED15-dependent upregulation of LONP2, coupling its expression to peroxisomal dysfunction (PMID:33472070). Beyond these roles in peroxisomal proteostasis and stress signaling, LONP2 has been implicated in promoting proliferation and migration in cancer cell models, acting upstream of the actin-bundling protein PLS3 (PMID:36347334).

1. 2016 Medium

   Established LONP2 as the peroxisome-localized Lon protease isoform dedicated to degrading oxidatively damaged proteins, distinguishing it from the mitochondrial LonP1 and assigning it a protein quality-control role in peroxisomes.

   Evidence comparative biochemical and cell biology review of Lon protease isoform literature

   PMID:26852705

   Open questions at the time

   • Review-level synthesis rather than a primary mechanistic experiment
   • No specific endogenous substrate identified
   • Age-related activity decline asserted but not mechanistically dissected
2. 2018 Medium

   Consolidated the view that LONP2 selectively degrades oxidatively damaged peroxisomal proteins to maintain proteostasis and extend organelle lifespan, framing peroxisomal proteolysis as a homeostatic mechanism.

   Evidence review synthesizing prior experimental studies on peroxisomal proteolysis

   PMID:29167332

   Open questions at the time

   • Review, not new primary data
   • Substrate selectivity determinants unresolved
   • Regulation of protease activity not defined
3. 2021 Medium

   Defined the upstream regulation of LONP2 by showing that peroxisomal import stress drives NHR-49/PPARα- and MDT-15/MED15-dependent transcriptional upregulation, placing LONP2 within a peroxisomal retrograde signaling pathway responsive to organelle dysfunction.

   Evidence RNAi knockdown, transcriptomics/proteomics, and genetic epistasis in C. elegans

   PMID:33472070

   Open questions at the time

   • Demonstrated in C. elegans; mammalian conservation of the PRS axis not shown here
   • Direct promoter-level regulation by the transcription factors not established
   • Downstream proteostatic consequences of induction not quantified
4. 2023 Medium

   Identified TYSND1 as a LONP2 substrate and linked LONP2 to broader peroxisomal integrity and inter-organelle lipid trafficking, showing depletion alters peroxisome morphology, impairs luminal import, and blocks cholesterol egress from late endosomes.

   Evidence siRNA silencing with proteomics, fluorescence microscopy, and lipid mass spectrometry in COS-7 and U2OS cells

   PMID:37736739

   Open questions at the time

   • Direct proteolytic cleavage of TYSND1 by LONP2 not reconstituted in vitro
   • Mechanism connecting peroxisomal LONP2 to late-endosomal cholesterol flux unresolved
   • Single lab, two cell lines
5. 2020 Low

   Linked LONP2 to ether lipid biosynthesis by showing autophagy loss in β-cells upregulates Lonp2 alongside facilitated maturation of ether lipid synthetic enzymes.

   Evidence conditional Atg7 knockout in β-cells, lipidomics, and gene expression analysis in MIN6 cells

   PMID:32504884

   Open questions at the time

   • LONP2 upregulation is correlative; its direct role in enzyme maturation not isolated
   • Causality between LONP2 and ether lipid changes untested
   • No substrate or biochemical mechanism shown
6. 2018 Low

   Implicated LONP2 in cervical tumorigenesis by showing knockdown reduces proliferation, migration, invasion, and ROS production.

   Evidence siRNA knockdown with viability, apoptosis/cell-cycle, ROS, and migration/invasion assays in HeLa and SiHa cells

   PMID:29502128

   Open questions at the time

   • No molecular substrate or mechanism linking LONP2 to ROS or tumor phenotype
   • Single cell-type pair, single lab
   • Whether effect is peroxisomal proteostasis-dependent unknown
7. 2022 Low

   Placed LONP2 upstream of the actin-bundling protein PLS3 in a pro-proliferative pathway in HNSCC, where LONP2 knockdown suppresses tumor growth and reduces PLS3, and PLS3 knockdown blocks LONP2-overexpression-driven proliferation.

   Evidence siRNA knockdown, overexpression, xenograft model, RNA-seq, and rescue assays in HNSCC cells

   PMID:36347334

   Open questions at the time

   • Mechanism linking LONP2 protease activity to PLS3 transcription not established
   • Whether the link is direct or indirect unknown
   • Single lab
8. 2021 Low

   Identified post-transcriptional regulation of LONP2 by miR-1287-5p and its induction during oxygen-glucose deprivation/reperfusion in neuronal cells.

   Evidence luciferase reporter assay, miRNA gain/loss of function, OGD/R model, and ROS measurement in SH-SY5Y cells

   PMID:34589382

   Open questions at the time

   • LONP2's specific protective or damaging role in OGD/R not directly dissected
   • miRNA-LONP2 axis effect on peroxisomal function untested
   • Single lab

• The biochemical determinants of LONP2 substrate selectivity and the mechanism coupling its peroxisomal proteolytic activity to downstream phenotypes (cholesterol flux, ether lipid maturation, PLS3 regulation, cancer proliferation) remain undefined.
• No in vitro reconstitution of LONP2 protease activity on identified substrates
• No structural model of human LONP2
• Mechanistic basis of non-peroxisomal phenotypes unresolved